RA Capital Nexus Fund III, L.P. — SEC insider filings

SEC reporting owner CIK 1883840. 57 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers the 50 most recent of 57 filings on record, filed 2024-09-18 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Parabilis Medicines, Inc. (PBLS)Director38 legs · 21,433,343 sh · $430,694,551—7
Septerna, Inc. (SEPN)Director42 legs · 4,170,000 sh · $75,060,0002 legs · 1,493,000 sh · $63,452,5006
Artiva Biotherapeutics, Inc. (ARTV)Director1320 legs · 8,642,543 sh · $92,678,453—4
Sionna Therapeutics, Inc. (SION)Director72 legs · 1,125,000 sh · $20,250,00046 legs · 3,989,088 sh · $43,298,48316
SpyGlass Pharma, Inc. (SGP)Director33 legs · 3,691,000 sh · $59,072,430—9
Mineralys Therapeutics, Inc. (MLYS)Director54 legs · 2,841,766 sh · $56,262,778—3
Bambusa Therapeutics, Inc. (BBTX)Director24 legs · 2,953,820 sh · $46,639,957—6
Bicara Therapeutics Inc. (BCAX)Director43 legs · 2,133,000 sh · $37,794,000—9
Climb Bio, Inc. (CLYM)Director73 legs · 321,672 sh · $779,626—14
Freenome, Inc. (FRNM)Director1——7

+1 more issuer among the filings shown — every filing appears in the table below.

Insider filings — RA Capital Nexus Fund III, L.P.

FiledFormIssuerReported transactionsSource
2026-11-184SpyGlass Pharma, Inc. (SGP)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 1,000 @ $32.43EDGAR
2026-11-034Bambusa Therapeutics, Inc. (BBTX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 189,909 @ $14.23 · Purchase (P): 263,911 @ $14.92 · Conversion (C): 3,144,858 · Conversion (C): 1,331,080 · Purchase (P): 2,335,109 @ $16 · Purchase (P): 164,891 @ $16 · +4 moreEDGAR
2026-10-293Bambusa Therapeutics, Inc. (BBTX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Holdings only — no transactions reportedEDGAR
2026-09-304Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Option exercise (M): 10,000 @ $3.46 · Option exercise (M): 10,000 @ $3 · Option exercise (M): 10,000 @ $7.89 · Option exercise (M): 40,000 @ $1.29 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · +2 moreEDGAR
2026-09-214Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Sale (S): 3,415,011 @ $6.32 · Sale (S): 33,800 @ $7.46EDGAR
2026-09-144Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-084Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 13,750 (derivative) @ $0EDGAR
2026-08-144Septerna, Inc. (SEPN)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Sale (S): 746,500 @ $42.50 · Sale (S): 746,500 @ $42.50EDGAR
2026-07-314Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 20,824 @ $9.99 · Purchase (P): 24,944 @ $9.93EDGAR
2026-07-284Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 41,319 @ $9.99EDGAR
2026-07-234/AArtiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 6,522 @ $8.94EDGAR
2026-07-234Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 120,582 @ $9.55 · Purchase (P): 84,124 @ $9.93 · Purchase (P): 59,880 @ $9.96EDGAR
2026-07-224Parabilis Medicines, Inc. (PBLS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 98,433 @ $27.13 · Purchase (P): 32,987 @ $27.72 · Purchase (P): 21,696 @ $27.96 · Purchase (P): 6,504 @ $29.17 · Purchase (P): 37,723 @ $30 · Purchase (P): 47,250 @ $29.77EDGAR
2026-07-224Freenome, Inc. (FRNM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 6,561,711 · Grant/award (A): 970,950 · Grant/award (A): 553,703 · Grant/award (A): 908,103 · Grant/award (A): 367,427 · Grant/award (A): 4,918,411 @ $10 · +1 moreEDGAR
2026-07-204Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 152,472 @ $8.93 · Purchase (P): 7,882 @ $8.95EDGAR
2026-07-144Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 15,102 @ $8.97 · Purchase (P): 6,552 @ $8.94EDGAR
2026-07-014Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 70,284 (derivative) @ $0EDGAR
2026-06-304Septerna, Inc. (SEPN)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-294Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 31,000 @ $8.88 · Purchase (P): 1,876 @ $8.98EDGAR
2026-06-184Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 17,340 (derivative) @ $0EDGAR
2026-06-164Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 391,019 @ $8.57 · Purchase (P): 15,414 @ $8.99 · Purchase (P): 124,893 @ $8.89EDGAR
2026-06-154Parabilis Medicines, Inc. (PBLS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 6,556,740 · Conversion (C): 1,187,881 · Purchase (P): 19,728,353 @ $20 · Purchase (P): 1,460,397 @ $20 · Conversion (C): 642,250 (derivative) · Conversion (C): 160,562 (derivative) · +2 moreEDGAR
2026-06-114Parabilis Medicines, Inc. (PBLS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 479,039 @ $6.91 · Purchase (P): 103 @ $7 · Purchase (P): 548,580 @ $7.91EDGAR
2026-06-104Bicara Therapeutics Inc. (BCAX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 19,475 (derivative) @ $0EDGAR
2026-06-084Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-05-134Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 6,510,416 @ $11.52 · Purchase (P): 2,170,138 (derivative) @ $11.52EDGAR
2026-04-294Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 2,106,000 (derivative) @ $9.50EDGAR
2026-03-314Mineralys Therapeutics, Inc. (MLYS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 310,700 @ $23.67 · Purchase (P): 58,300 @ $24.16EDGAR
2026-03-024Bicara Therapeutics Inc. (BCAX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 300,000 @ $16 · Purchase (P): 2,200,000 (derivative) @ $16.00EDGAR
2026-02-204Mineralys Therapeutics, Inc. (MLYS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2026-02-174Evommune, Inc. (EVMN)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 35,868 @ $27.88EDGAR
2026-02-114SpyGlass Pharma, Inc. (SGP)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 2,524,473 · Conversion (C): 1,806,644 · Purchase (P): 3,441,966 @ $16 · Purchase (P): 248,034 @ $16 · Conversion (C): 1,150,941 (derivative) · Conversion (C): 767,294 (derivative) · +4 moreEDGAR
2026-02-094SpyGlass Pharma, Inc. (SGP)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 27,400 (derivative) @ $0EDGAR
2026-01-074Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 7,111 @ $3.50EDGAR
2025-12-154Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Disposition to issuer (D): 20,440,000 @ $0 · Purchase (P): 213,099 @ $2.18 · Purchase (P): 101,462 @ $2.86 · Grant/award (A): 20,440,000 (derivative)EDGAR
2025-11-244Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Sale (S): 150 @ $39.89 · Sale (S): 1,235 @ $39.89 · Sale (S): 801 @ $39.89 · Sale (S): 947 @ $39.89 · Sale (S): 96 @ $40.50 · Sale (S): 788 @ $40.50 · +6 moreEDGAR
2025-11-194Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Sale (S): 2,182 @ $40.20 · Sale (S): 17,913 @ $40.20 · Sale (S): 11,626 @ $40.20 · Sale (S): 13,734 @ $40.20 · Sale (S): 1,701 @ $41.05 · Sale (S): 13,964 @ $41.05 · +18 moreEDGAR
2025-10-284Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Sale (S): 14,116 @ $39.50 · Sale (S): 122,271 @ $39.50 · Sale (S): 66,672 @ $39.50 · Sale (S): 107,941 @ $39.50 · Sale (S): 3,624 @ $39.58 · Sale (S): 31,392 @ $39.58 · +2 moreEDGAR
2025-09-084Mineralys Therapeutics, Inc. (MLYS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 1,176,470 @ $25.50EDGAR
2025-06-264Artiva Biotherapeutics, Inc. (ARTV)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 13,750 (derivative) @ $0EDGAR
2025-06-204Septerna, Inc. (SEPN)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 16,623 (derivative) @ $0EDGAR
2025-06-164Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 19,959 (derivative) @ $0EDGAR
2025-06-104Bicara Therapeutics Inc. (BCAX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 23,746 (derivative) @ $0EDGAR
2025-06-054Climb Bio, Inc. (CLYM)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-03-174Mineralys Therapeutics, Inc. (MLYS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Purchase (P): 1,296,296 @ $13.50EDGAR
2025-02-244Mineralys Therapeutics, Inc. (MLYS)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Grant/award (A): 32,900 (derivative) @ $0EDGAR
2025-02-104Sionna Therapeutics, Inc. (SION)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 5,021,990 · Conversion (C): 527,444 · Conversion (C): 2,222,084 · Conversion (C): 179,975 · Purchase (P): 1,022,586 @ $18 · Purchase (P): 102,414 @ $18 · +10 moreEDGAR
2024-10-304Septerna, Inc. (SEPN)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 1,695,515 · Conversion (C): 1,130,343 · Purchase (P): 3,828,400 @ $18 · Purchase (P): 341,600 @ $18 · Conversion (C): 14,598,896 (derivative) · Conversion (C): 9,732,596 (derivative)EDGAR
2024-09-184Bicara Therapeutics Inc. (BCAX)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 2,622,898 · Conversion (C): 2,500,095 · Purchase (P): 1,680,520 @ $18 · Purchase (P): 152,480 @ $18 · Conversion (C): 18,409,755 (derivative) · Conversion (C): 12,273,169 (derivative) · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1883840 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs